Chemotherapy-induced Nausea and Vomiting Drugs Market

List of Tables
Table 1. Chemotherapy-induced Nausea and Vomiting Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Chemotherapy-induced Nausea and Vomiting Drugs Market Trends
Table 3. Chemotherapy-induced Nausea and Vomiting Drugs Market Drivers
Table 4. Chemotherapy-induced Nausea and Vomiting Drugs Market Challenges
Table 5. Chemotherapy-induced Nausea and Vomiting Drugs Market Restraints
Table 6. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Chemotherapy-induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-induced Nausea and Vomiting Drugs as of 2021)
Table 18. Top Players of Chemotherapy-induced Nausea and Vomiting Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Product Type
Table 20. Date of International Manufacturers Enter into Chemotherapy-induced Nausea and Vomiting Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Chemotherapy-induced Nausea and Vomiting Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Merck Chemotherapy-induced Nausea and Vomiting Drugs Product
Table 46. Merck Recent Development
Table 47. Eisai Corporation Information
Table 48. Eisai Description and Business Overview
Table 49. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Eisai Product
Table 51. Eisai Recent Development
Table 52. Mundipharma Corporation Information
Table 53. Mundipharma Description and Business Overview
Table 54. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Mundipharma Product
Table 56. Mundipharma Recent Development
Table 57. Qilu Pharma Corporation Information
Table 58. Qilu Pharma Description and Business Overview
Table 59. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Qilu Pharma Product
Table 61. Qilu Pharma Recent Development
Table 62. Teva Corporation Information
Table 63. Teva Description and Business Overview
Table 64. Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Teva Product
Table 66. Teva Recent Development
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Novartis Product
Table 71. Novartis Recent Development
Table 72. Heron Therapeutics Corporation Information
Table 73. Heron Therapeutics Description and Business Overview
Table 74. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Heron Therapeutics Product
Table 76. Heron Therapeutics Recent Development
Table 77. Roche Corporation Information
Table 78. Roche Description and Business Overview
Table 79. Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Roche Product
Table 81. Roche Recent Development
Table 82. Mylan Corporation Information
Table 83. Mylan Description and Business Overview
Table 84. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Mylan Product
Table 86. Mylan Recent Development
Table 87. Tesaro Corporation Information
Table 88. Tesaro Description and Business Overview
Table 89. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Tesaro Product
Table 91. Tesaro Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Chemotherapy-induced Nausea and Vomiting Drugs Customers List
Table 95. Chemotherapy-induced Nausea and Vomiting Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy-induced Nausea and Vomiting Drugs Product Picture
Figure 2. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales 2017-2028 (K Units)
Figure 5. United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Chemotherapy-induced Nausea and Vomiting Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales 2017-2028 (K Units)
Figure 8. United States Chemotherapy-induced Nausea and Vomiting Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Chemotherapy-induced Nausea and Vomiting Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Chemotherapy-induced Nausea and Vomiting Drugs Report Years Considered
Figure 11. Product Picture of 5-HT3 Inhibitors
Figure 12. Product Picture of NK1 Inhibitors
Figure 13. Product Picture of Other
Figure 14. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2017-2028) & (K Units)
Figure 18. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Type in 2022 & 2028
Figure 21. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2017-2028) & (K Units)
Figure 24. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Highly Emetogenic Chemotherapy
Figure 27. Product Picture of Moderately Emetogenic Chemotherapy
Figure 28. Product Picture of Low Emetogenic Chemotherapy
Figure 29. Product Picture of Other
Figure 30. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2017-2028) & (K Units)
Figure 34. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2017-2028) & (K Units)
Figure 40. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. United States Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 48. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. UK Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 55. Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Vietnam Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 67. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 72. Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. UAE Chemotherapy-induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Chemotherapy-induced Nausea and Vomiting Drugs Value Chain
Figure 77. Chemotherapy-induced Nausea and Vomiting Drugs Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed